Clinical Trials Browser

Phase 2 × etoposide phosphate × 30 days × Clear all

NCT02583893 2026-05-29

Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia

Phase 2 Completed

39 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Phase 2 Recruiting

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell